Flora Growth Corp SEC Filings

Flora Growth Corp. (FLGC) prospectus supplement highlights material risks and security descriptions for offered securities. The document lists multiple risk factors that could reduce investor confidence or depress the value of the 0G token, including heavy retail or institutional trading activity, large holder dispositions (including government-seized or bankruptcy-liquidated assets and team-vested tokens), declines in other digital assets, adverse publicity, and competition from faster, more secure or government-backed alternatives. It describes technological risks to the 0G Blockchain such as protocol changes, failed upgrades, software bugs, congestion and fees. It warns of counterparty risks from custodians, trading venues and platforms, and of regulatory, legislative, enforcement or judicial actions that could limit access, transferability or functionality. The prospectus also summarizes rights of common shares and extensive potential terms and mechanics for warrants and units, including exercise periods, transferability, and tax consequences, and lists SEC filings incorporated by reference.

Flora Growth Corp. disclosed proposed token and securities financings including a Token Private Placement of 8,546,955 pre-funded warrants at US$25.1899 each, each exercisable for one common share at US$0.0001 upon shareholder approval, with token consideration valued at US$3.00 each. The company also described convertible notes tied to Solana or Tokens that, subject to shareholder approval, may convert into common shares at a conversion ratio based on a US$33.34 reference price and specified U.S. Dollar value calculations. A Loan Agreement with Zero Gravity Labs to borrow Tokens includes issuance of 1,786,423 warrants exercisable at US$0.01. Several agreements include outside/early termination mechanics and optional in-kind interest capitalization through September 30, 2026.

Highbridge Capital Management, LLC filed an amendment to Schedule 13G reporting beneficial ownership of 1,038,240 common shares of Flora Growth Corp. (FLGC), representing 4.4% of the outstanding common shares on a fully‑diluted basis assuming exercise of warrants. The shares reported are issuable upon exercise of warrants directly held by funds managed by Highbridge. The filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The reporting person is a Delaware investment adviser with a New York business address.